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SUMMARY
One hundred consecutive patients with haematuria were seen over a three month period at the
haematuria clinic, Belfast City Hospital. 14% of patients were found to have transitional cell
carcinoma oftheurinary bladder; all ofthesepresented withfrankhaematuriaand were over50
years ofage. No malignancy was detected in the microscopic haematuria group. 14% ofpatients
with macroscopic haematuria held back for longer than one month before seeking advice from
their general practitioner. 23% with macroscopic and 30% with microscopic haematuria had
their symptoms noted by the general practitioner for more than a month before they were
referred forinvestigation. The waiting time forinitial investigation atthehaematuria clinic took
longerthansixweeksin52% withmacroscopicand39% withmicroscopichaematuria. Ourstudy
has identified a high-risk group who need immediate referral and investigation. The importance
of patient education, rapid referral by general practitioners and also the need to increase the
capacity ofthe haematuria clinic are emphasized.
INTRODUCTION
Haematuriais oftenthefirstpresenting sign ofan
underlying urological malignancy. Urological
malignancy hasbeenreportedin 14.7 to 21.8% of
patients with macroscopic haematurial 2 and in
upto2%ofpatientswithmicroscopichaematuria.3
The commonest malignancy presenting with this
symptomistransitionalcellcarcinomamostoften
involving the bladder (TCCB).
Most bladder tumours are curable if detected at
an early stage and if appropriate treatment is
instituted.4'5 Asthediseaseprogresses, prognosis
decreases markedly and the 5 year survival for
muscle-invasivebladdercancerafterconventional
treatment with radiotherapy or cystectomy or in
combination is at best 35% - 45%.6-8 Both the
depth ofinvasion anddevelopmentofmetastases
are time-dependent and Hendry et a19 has shown
that with early diagnosis an increasedproportion
of potentially curable T2 tumours are detected.
The data support the assertion that delay in
detectingandinstituting treatmenthas anadverse
effect on patient survival.
The investigation of haematuria commonly
involves a delay before treatment is undertaken.
The causes of this may be attributed to delay by
the patient in seeking medical advice, general
practitioner delay in referring for investigation
and hospital delay in providing timely
investigation.
Patients with haematuria as a rule tend to seek
advice quickly.4' 9, 10 Therefore the delays in
initiating treatment may be the responsibility of
medical personnel. Studies have indicated that
the average time delay from general practitioner
referral to diagnostic cystoscopy is fourweeks."I
Haematuria clinics have been set up across the
United Kingdom to provide an investigative
service for patients with haematuria in an effort
todecreasethemorbidity andmortalitybyearlier
diagnosis of urological malignancy. This paper
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delays in the investigation of patients with
haematuriareferredtotheDepartmentofUrology,
Belfast City Hospital, Northern Ireland.
Regional Urology Unit, Level 3, Belfast City Hospital,
Belfast BT9 7AB.
E T S Ho, FRCSEd, Specialist Registrar in Urology.
S R Johnston, FRCS, Consultant Urologist.
P F Keane, MCh, FRCS (Urol), Consultant Urologist.
Correspondence to Mr Ho.
C The Ulster Medical Society, 1998.26 The Ulster Medical Journal
PATIENTS AND METHODS
Our study included 100 consecutive patients
attendingthehaematuriaclinicbetweenMay 1995
andAugust 1995.Followingreferralbythegeneral
practitioner for investigation of frank or
microscopic haematuria, patients were seenatthe
haematuria clinic (scheduled once a week) at the
Day Procedure Unit, Belfast City Hospital. A
history was taken of their complaint including
details of the onset of symptoms and when they
were seen by their general practitioner. The date
of referral was taken from the general
practitioner's referral letter. Following this,
patients underwent a flexible cystoscopy under
local anaesthesia (2% lignocaine gel).
Any new case ofbladder cancer detected had an
urgent intravenous urogram (IVU) and they were
placed on the next available operating list of the
appropriate consultant fortransurethral resection
undergeneral orregional anaesthesiato stageand
grade the tumour. All otherpatients had aroutine
IVU requested on an outpatient basis and were
given early appointments to the clinic for further
assessment.
RESULTS
Over the period May 1995 to August 1995, 100
patients (64 males, 36 females) with mean age of
57 years (range 18 - 87) were referred to the
haematuriaclinic. 56patients (56%)werereferred
with frank haematuria, and 44 patients (44%)
with microscopic haematuria discovered on
routine testing.
TABLE 1







Benign prostatic hyperplasia 5
Previous transurethral resection
of prostate 3
Bladder neck stenosis 2
Urethral stricture 2
Meatal Stenosis 1
Diagnoses made at the haematuria clinic are
shown in Table I. Fourteen patients (14%) had
TCCB and all these presented with frank
haematuria. The mean age of these patients was
71 years (range 53 -82). No malignancies were
detected in the microscopic haematuria group in
this study.
Eight patients (8%) had macroscopic haematuria
related to their prostate. Three patients had
previously undergone transurethral resection of
their prostate and had prominent vessels at the
bladder neck which bled on contact. The
remaining five patients had mild to moderate
outflow obstructive symptoms, and were found
to have an enlarged prostate with congested
mucosa overlying the gland and bladder neck.
Thirty-three (60%) patients with macroscopic
haematuriapresentedtotheirgeneralpractitioners
within one week, and by four weeks, forty-eight
(86%) patients had sought advice from their
general practitioner Table II.
TABLE II
Time betweenpatientnoticing/detecting symptoms
andattending generalpractitioner in the
macroscopic haematuria group (patientdelay).
Patient delay Macroscopic
haematuria
< 1 week 33 (60%)
1 - 4 weeks 15 (26%)
> 4 weeks 8 (14%)
Total 56
77%withmacroscopic, and70% withmicroscopic
haematuria were referred by the general
practitioner for investigation within one month
ofpresentationTableIII. Withinthefirstweekof
attending, 32% ofpatients withmacroscopic, and
25% with microscopic haematuria had been
referred. However, 14% of patients with
macroscopic haematuriahad symptoms formore
thantwomonthsbeforebeingreferredforhospital
investigation.
The mean time from referral by the general
practitioner to attendance at the clinic was six
weeks (range 2 - 12 weeks). Only 18% with
macroscopic and 25% with microscopic
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Table III
Time between attending general practitioner to referral (general practitioner delay).
GP delay Macroscopic Microscopic Allpatients(%
haematuria haematuria
< I week 18 (32%) 11 (25%) 29
1 - 4 weeks 25 (45%) 20 (45%) 45
5-8weeks 5( 9%) 6(14%) 11
> 8 weeks 8 (14%) 7 (16%) 15
Total 56 44 100
haematuria were investigated within four weeks
ofreferral. However, 48% withmacroscopic and
61% with microscopic haematuria were
investigated within six weeks ofreferral by their
generalpractitioner. Theremainingpatients, 52%
with macroscopic, and 39% with microscopic
haematuria, took longer than six weeks to have
their initial investigation Table IV.
TABLE IV
Time between generalpractitioner referral to
attendance atthe haematuria clinic (hospitaldelay).
Hospital Macroscopic Microscopic
delay haematuria haematuria
< 2 weeks 0 2 (5%)
2 - 4 weeks 10 (18%) 9 (20%)
4 - 6 weeks 17 (30%) 16 (36%)
6 - 8 weeks 23 (41%) 13 (30%)




minimal delay is well established. Our study has
shownthatpatients attending ahaematuria clinic
have a 27% rate of a definitive pathological
diagnosis being made. In particular, 14% of
patients had urothelial malignancy, all having
had macroscopic haematuria as the presenting
symptom; and all were over 50 years ofage. The
malignancy rate in this study is higher than the
rate of2- 1 % t reportedbyothers.3' 12Although in
this study, no patients with microscopic
haematuria had malignancy in the lower urinary
tract, otherlargerstudies' havereportedupto2%
pick-up rate of malignancy in patients with
microscopic haematuria. While all patients with
haematuria require investigation, our results
suggest that those with macroscopic haematuria
requireurgentreferralandshouldhavecompleted
investigations within fourweeks ofpresentation.
This study supports the findings of others that
patients with macroscopic haematuria tend to
seek advice early. 4 9 10 Wallace and Harris4
showed that 75% of their patients attended their
general practitioner within one month of
developing haematuria and our study showed
that86%attendedtheirgeneralpractitionerwithin
the month. However, 14% patients with
macroscopic haematuria waited more than one
month before seeking the general practitioner's
help. We were able to identify two majorreasons
for the delay in patients with macroscopic
haematuria referring themselves for diagnosis.
One was the fearofthe diagnosis ofmalignancy;
and the second was the lack of urgency because
of previous history of haematuria either due to
urinarytractinfectionsorcalculusdisease.Among
the eight patients who delayed more than four
weeks in attending the general practitioner, one
wasfoundtohavemalignancy.Thisfindingwould
suggest that better patient education as to the
significance of haematuria is required.
In our study, 77% with macroscopic haematuria,
and 70% with microscopic haematuria were
referredwithinfourweeksofattendingthegeneral
practitioner. However, 23% of those with
macroscopic haematuria, and up to 30% with
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microscopic haematuria had their symptoms for
more than a month before they were referred for
hospital investigation. It is clear fromourresults
that patients with macroscopic haematuria need
to be referred immediately by their general
practitioner. Repeated urinalysis and urinary
bacteriology should not delay referral in this
macroscopic category. Those with microscopic
haematuria can be commenced on antibiotic
therapy if symptoms of UTI are present and if
asymptomatic microscopic haematuria persists
then they should be referred for hospital
investigations without delay. It is clear that the
waitingtimeforpatients to attendthehaematuria
clinic is too long, with 82% with macroscopic
haematuriaand75%withmicroscopichaematuria
waiting longerthanfourweeks. Somereasons for
delay were:-
1. patients who could/did not attend andhadto
be re-appointed
2. inappropriatereferralstothegeneralsurgeon,
gynaecologist or renal physician etc., who
then refers these patients to us
3. insufficient number of sessions allocated to
the haematuria clinic
The ideal would be for patients to be seen at the
haematuria clinic within four weeks ofthe onset
of symptoms." Therefore, to reduce the waiting
time for patients to be seen at the haematuria
clinic, all patients with haematuria should be
referred to the urology service and this service
should increase thenumberofhaematuriaclinics
to two per week.
Our study has highlighted a high risk group of
patients withpainlessfrankhaematuriaabovethe
age of 50 years of age who require immediate
referral andinvestigation. Ithas also emphasised
the importance of patient education in reducing
delay in seeking medical attention and the need
forthegeneralpractitionertoreferpatientsearlier
especially if the patient presents with painless
frank haematuria. It has become apparent to us
that in order to offer an efficient service for the
investigation ofhaematuria, we would need two
clinics per week to reduce the waiting time of
those referred.
C) The Ulster Medical Society, 1998.
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